Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
出版年份 2018 全文链接
标题
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
作者
关键词
-
出版物
Alzheimers Research & Therapy
Volume 10, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-25
DOI
10.1186/s13195-018-0426-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia
- (2018) Andrew P. Merluzzi et al. NEUROLOGY
- Biomarkers of Alzheimer's Disease Among Mexican Americans
- (2018) Sid E. O'Bryant et al. JOURNAL OF ALZHEIMERS DISEASE
- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
- (2017) Fayçal Ben Bouallègue et al. Alzheimers Research & Therapy
- Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
- (2017) K Höglund et al. Translational Psychiatry
- CSF Levels of Heart Fatty Acid Binding Protein are Altered During Early Phases of Alzheimer's Disease
- (2017) Davide Chiasserini et al. JOURNAL OF ALZHEIMERS DISEASE
- Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry
- (2016) Josef Pannee et al. Alzheimers & Dementia
- Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: A case–control study
- (2016) Kei Hamazaki et al. SCHIZOPHRENIA RESEARCH
- Reference tissue normalization in longitudinal 18F-florbetapir positron emission tomography of late mild cognitive impairment
- (2016) Sepideh Shokouhi et al. Alzheimers Research & Therapy
- CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
- (2016) William T. Hu et al. Acta Neuropathologica Communications
- Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease
- (2015) Daniela Bertens et al. Alzheimers & Dementia
- High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid
- (2015) Ronald C. Hendrickson et al. PLoS One
- Phosphorylated Tau-Aβ 42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
- (2014) Oscar Harari et al. BIOLOGICAL PSYCHIATRY
- Elevated Serum Pesticide Levels and Risk for Alzheimer Disease
- (2014) Jason R. Richardson et al. JAMA Neurology
- CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?
- (2014) William T. Hu et al. Annals of Clinical and Translational Neurology
- Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
- (2013) Rahul S Desikan et al. Molecular Neurodegeneration
- Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP
- (2013) W. T. Hu et al. NEUROLOGY
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Plasma heart-type fatty acid binding protein level in acute ischemic stroke: Comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome
- (2012) So-Young Park et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
- (2012) W. T. Hu et al. NEUROLOGY
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
- (2011) Rebecca Craig-Schapiro et al. PLoS One
- Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
- (2010) William T. Hu et al. ACTA NEUROPATHOLOGICA
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases
- (2010) C. E. Teunissen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Heart-Type Fatty Acid Binding Protein Regulates Dopamine D2 Receptor Function in Mouse Brain
- (2010) N. Shioda et al. JOURNAL OF NEUROSCIENCE
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now